Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607082 · ClinicalTrials.gov registry record · NA
COVID-19 Bivalent Booster Megastudy
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 2,600,000
- Enrollment target
NCT05607082: Completed NA study, sponsored by University of Pennsylvania.
NCT05607082 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 2,600,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05607082, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,600,000 participants
- Enrollment target
Study Summary
This megastudy is a massive randomized controlled trial. By randomizing participants to 10 different intervention conditions simultaneously, the investigators will be able to compare the effectiveness of different interventions to one another and to a control group (in which individuals will only receive the usual communications from their partner organization) to identify which interventions significantly increase vaccination rates. Pharmacy customers will be randomly assigned to receive one of the interventions designed by team scientists to encourage vaccination or to a control group. The baseline intervention will be based on the top-performing SMS intervention identified in the investigators previous megastudies on encouraging vaccination (Milkman et al., 2021b, 2022). Pharmacy customers will receive SMS messages conveying that a COVID booster vaccine is reserved or waiting for them at the pharmacy. Additional behavioral science messaging strategies will be tested by building off of this baseline intervention.
Interventions
- BEHAVIORAL COVID Booster text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,600,000 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2023-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05607082
The ClinicalTrials.gov registry entry for NCT05607082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,600,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID Booster text messages is the first listed.
NCT05607082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05607082 about?
NCT05607082 is a clinical study titled "COVID-19 Bivalent Booster Megastudy". This megastudy is a massive randomized controlled trial. By randomizing participants to 10 different intervention conditions simultaneously, the investigators will be able to compare the effectiveness of different interventions to one another and to a control group (in which individuals will only re...
What is the current status of trial NCT05607082?
This trial is currently completed. It is a NA study. The enrollment target is 2,600,000 participants. The study started on 2022-11-03. Estimated completion is 2023-02-06.
What interventions are being tested in trial NCT05607082?
The interventions under investigation include: COVID Booster text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05607082?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.